Literature DB >> 15302707

In search of the holy grail: lung cancer biomarkers.

Douglas Arenberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15302707     DOI： 10.1378/chest.126.2.325

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  3 in total

1.  RUNX3 downregulation in human lung adenocarcinoma is independent of p53, EGFR or KRAS status.

Authors:  Mohd Feroz Mohd Omar; Kosei Ito; Min En Nga; Ross Soo; Bee Keow Peh; Tuty Muliana Ismail; Bhavin Thakkar; Richie Soong; Yoshiaki Ito; Manuel Salto-Tellez
Journal:  Pathol Oncol Res       Date:  2012-06-24       Impact factor: 3.201

2.  Multi-analyte assays and early detection of common cancers.

Authors:  Robert P Young; Timothy Christmas; Raewyn J Hopkins
Journal:  J Thorac Dis       Date:  2018-07       Impact factor: 2.895

3.  Systemic miRNA-195 differentiates breast cancer from other malignancies and is a potential biomarker for detecting noninvasive and early stage disease.

Authors:  Helen M Heneghan; Nicola Miller; Ronan Kelly; John Newell; Michael J Kerin
Journal:  Oncologist       Date:  2010-06-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.